N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: a systematic review

Eur Neuropsychopharmacol. 2014 Oct;24(10):1659-75. doi: 10.1016/j.euroneuro.2014.06.004. Epub 2014 Jul 4.

Abstract

The amino-acid N-acetyl-aspartate (NAA) is located in neurons and the concentration of NAA correlates with neuronal mitochondrial function. The signal of NAA, as measured with proton magnetic resonance spectroscopy (1H-MRS), is considered to reflect both, neuronal density and integrity of neuronal mitochondria. A reduction of the NAA concentrations has been found in several psychiatric disorders. Newer studies report reversal of decreased NAA concentration with treatment. The objective of this review is to summarize the literature on NAA changes in association with psychopharmacological treatment in psychiatric disorders (affective disorders, obsessive-compulsive disorder, schizophrenia and dementia). The majority of studies identified increased NAA concentrations in response to treatment, while a smaller number of studies did not find this effect. The NAA increase seems to be neither specific for a certain disorder nor for a specific intervention. This suggests that the reduction of NAA may represent an altered functional (metabolic) state of neurons common to different psychiatric disorders and the increase after treatment to indicate functional restoration as one general effect of interventions.

Keywords: Affective disorder; Alzheimer dementia; N-acetyl-aspartate; Obsessive compulsive disorder; Proton-MR-spectroscopy; Schizophrenia.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Aspartic Acid / analogs & derivatives*
  • Aspartic Acid / metabolism
  • Brain / drug effects*
  • Brain / metabolism*
  • Humans
  • Mental Disorders / drug therapy*
  • Mental Disorders / metabolism*
  • Proton Magnetic Resonance Spectroscopy

Substances

  • Aspartic Acid
  • N-acetylaspartate